Antengene Presents Results from Two Late-Stage Clinical Studies of Selinexor at ASH 2024
Press Releases
Antengene Corporation Limited  
December 10, 2024

Antengene Presents Results from Two Late-Stage Clinical Studies of Selinexor at ASH 2024

SHANGHAI and HONG KONG, Dec. 9, 2024 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or

avatar profile Olean Times Herald

Olean Times Herald


Local & Social